INHIBITORS OF METALLOPROTEINASES, THEIR USING AND PHARMACEUTICAL COMPOSITIONS BASED ON THEREOF Russian patent published in 2007 - IPC C07D233/78 C07D401/12 C07D403/12 C07D405/12 A61K31/4166 A61K31/454 A61K31/4439 A61P11/00 A61P19/00 A61P29/00 A61P35/00 

Abstract RU 2293729 C2

FIELD: organic chemistry, biochemistry, medicine, pharmacy.

SUBSTANCE: invention describes compound of the formula (I): wherein X represents -NR1; Y1 and Y2 represent oxygen atom (O); Z is chosen from -SO2N(R6), -N(R7)SO2; m = 1 or 2; A is chosen from a direct bond, (C1-C6)-alkyl; R1 represents hydrogen atom (H); each R2 and R3 is chosen independently from H, alkyl, aryl, alkylaryl, arylalkyl; each R4 is chosen independently from H, (C1-C3)-alkyl; R6 is chosen from H, alkyl, aryl, heteroaryl, alkylaryl, alkyl-heteroaryl, arylalkyl, heteroaryl-alkyl; R2 and R6 can join to form a ring comprising up to 7 ring atoms, or R3 and R6 can join to form a ring comprising up to 7 ring atoms, or R4 and R6 can join to form a ring comprising up to 7 ring atoms; R5 represents monocyclic, bicyclic or tricyclic group comprising one or two ring structures wherein each of that comprises up to 7 ring atoms chosen independently from cycloalkyl, aryl, heterocycloalkyl or heteroaryl and possibly substituted; when R5 represents bicyclic group then each ring structure is bound with the next ring structure through a direct bond, through -O-, through (C1-C6)-alkyl or condensed with this next ring structure; R7 is chosen from (C1-C6)-alkyl. Also, invention describes compound of the formula (II) given in the description, pharmaceutical compositions and using compound of the formula (I) or the formula (II) in preparing a medicine for using in treatment of disease or state mediated by one or more enzymes and representing metalloproteinase. Represented compounds are useful as inhibitors of metalloproteinases and especially as inhibitors of MMP12.

EFFECT: valuable medicinal and biochemical properties of inhibitors and pharmaceutical compositions.

20 cl, 3 tbl, 6 ex

Similar patents RU2293729C2

Title Year Author Number
INHIBITORS OF METALLOPROTEINASES, THEIR USING AND PHARMACEUTICAL COMPOSITIONS BASED ON THEREOF 2002
  • Lepiste Matti
  • Munk Af Rozenskel'D Magnus
RU2293730C2
INHIBITORS OF METALLOPROTEINASES, THEIR USING AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF 2002
  • Ehriksson Anders
  • Lepiste Matti
  • Lundkvist Mikaehl'
  • Munk Af Rozenskel'D Magnus
  • Zlatojdskij Pavol
RU2288228C2
DERIVATIVES OF IMIDAZOLIDINE-2,4-DIONE, PHARMACEUTICAL COMPOSITIONS COMPRISING THEREOF AND THEIR USING 2002
  • Munk Af Rozenskel'D Magnus
RU2285695C2
NEW HYDANTOIC DERIVATIVES FOR TREATING OBSTRUCTIVE AIRWAY DISEASES 2005
  • Gabos Balint
  • Ripa Lena
  • Stenvall' Kristina
RU2386629C2
2,5-DIOXOIMIDAZOLIN-4-YL METHYLCARBONYL COMPOUNDS, METHOD OF OBTAINING THEM, PHARMACEUTICAL MIXTURES CONTAING THEM AND THIR USE IN MEDICINE PREPARATION 2003
  • Khenriksson Krister
  • Munk Af Rozenkhol'D Magnus
RU2326117C2
NEW DERIVATIVES OF HYDANTOIN AS INHIBITORS OF METAL PROTEINASES 2005
  • Gabos Balint
  • Lundkvist Mikaehl'
  • Munk Af Rozenshel'D Magnus
  • Shamovski Igor'
  • Zlatojdski Pavol
RU2376301C2
P38 KINASE-INHIBITING ISOQUINOLINE DERIVATIVES 2009
  • Broukh Stiven Dzhon
  • Laker Timoti Dzhon
  • Roberts Brajan Glin
  • Sejnt-Gehllehj Stiven Ehntoni
RU2512318C2
NOVEL HYDANTOIN DERIVATIVES AS METALLOPROTEINASE INHIBITORS 2005
  • Gabos Balint
  • Lundkvist Mikaehl'
  • Munk Af Rozenshel'D Magnus
  • Shamovski Igor'
  • Zlatojdski Pavol
RU2378269C2
HYDANTOIN DERIVATIVES USED AS MMP INHIBITORS 2007
  • Chapman Dehvid
  • Gabos Balint
  • Munk Av Rozenshold Magnus
RU2463301C2
METHOD FOR PREPARING PYRAZOLE-CARBOXYLIC ACID DERIVATIVES 2013
  • Bartels Bern
  • Bliss Frits
  • Grebke Tsbinden Katrin
  • Kerner Mattias
RU2638112C2

RU 2 293 729 C2

Authors

Ehriksson Anders

Lepiste Matti

Lundkvist Mikaehl'

Munk Af Rozenskel'D Magnus

Zlatojdskij Pavol

Dates

2007-02-20Published

2002-03-13Filed